Indivior Pharmaceuticals Inc (INDV) Research

Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.

Market snapshot

Symbol
INDV
Price
$38.30
Day change
+0.98%
Market cap
$4.8B
P/E ratio
19.13x
52-week range
13.45-41
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Next earnings
in 1 month
Analyst price target
$48.00

Peer companies

  • ACADIA Pharmaceuticals Inc. (ACAD)
  • ADMA Biologics, Inc. (ADMA)
  • Amneal Pharmaceuticals, Inc. (AMRX)
  • Crinetics Pharmaceuticals, Inc. (CRNX)
  • Hinge Health, Inc. (HNGE)
  • Lantheus Holdings, Inc. (LNTH)
  • Option Care Health, Inc. (OPCH)
  • Praxis Precision Medicines, Inc. (PRAX)

Recent insider activity

  • Heidbreder Christian — S-Sale (18586 shares) on 2026-06-11
  • Preblick Ryan — S-Sale (36000 shares) on 2026-06-08
  • Thompson Juliet — A-Award (6518 shares) on 2026-05-13
  • Thompson Juliet — F-InKind (1117 shares) on 2026-05-12
  • Humphreys Keith — A-Award (6518 shares) on 2026-05-13

Open Indivior Pharmaceuticals Inc (INDV) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.